In Primary Care, Is Measuring Free-Thyroxine Plus Thyroid-Stimulating Hormone to Detect Hypopituitarism Cost-Effective? A Cost Utility Analysis Using Markov Chain Models
BMJ Open - United Kingdom
doi 10.1136/bmjopen-2019-029369
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 1, 2019
Authors
Publisher
BMJ